Investors & Media
Investors & MediaNews release
News release
| News VasThera signs MoU with IBS for Study on the Mechanism of New Molecular Compounds | |
|---|---|
| VasThera(choisy@vasthera.com)Date : 2022-09-27View : 2860 | |
|
▲ VasThera signs MoU with IBS for Study on the Mechanism of New Molecular Compounds
▲ VasThera-IBS Group Photo
|
|
| Prev | Dr. Sang Won Kang attended a business exchange meeting at the Korea Biotech Industry Organization |
| Next | VasThera’s Dr. Sang Won Kang to Present at the 2022 BIO International Convention |
TOP